1
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
2
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie Jose, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021